Browse Tag

during the second half of 2020

Pfizer Invests USD 120 Million in biotechnology innovation Through the Pfizer Breakthrough Growth Initiative

1 min read

The FINANCIAL -- Pfizer Inc. announced that, during the second half of 2020, it invested a total of $120 million in four clinical-stage biotech companies as part of the Pfizer Breakthrough Growth Initiative (PBGI). Through PBGI, Pfizer is investing up to $500 million in biotechnology companies, providing funding and access to Pfizer’s scientific expertise to help ensure the continuity of promising clinical development programs of potential future strategic interest to Pfizer.…

Read More »

Pfizer Invests USD 120 Million in biotechnology innovation Through the Pfizer Breakthrough Growth Initiative

1 min read

The FINANCIAL -- Pfizer Inc. announced that, during the second half of 2020, it invested a total of $120 million in four clinical-stage biotech companies as part of the Pfizer Breakthrough Growth Initiative (PBGI). Through PBGI, Pfizer is investing up to $500 million in biotechnology companies, providing funding and access to Pfizer’s scientific expertise to…